XML 24 R11.htm IDEA: XBRL DOCUMENT
v3.23.1

REVENUES | 3 Months Ended
--- | ---
Mar. 31, 2023
REVENUES |
REVENUES | NOTE 4 – REVENUES ​ The following table summarizes the Company’s disaggregation of revenues:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended March 31, | ​ | ​
(U.S. dollars in thousands) |  | 2023 |  | 2022 | ​ | ​
Pfizer | ​ | $ | 2,266 | ​ | $ | 3,356 | ​ | ​
Brazil | ​ | $ | 2,800 | ​ | $ | 5,454 | ​ | ​
Chiesi | ​ | $ | — | ​ | $ | 218 | ​ | ​
Total revenues from selling goods | ​ | $ | 5,066 | ​ | $ | 9,028 | ​ | ​
Revenues from license and R&D services | ​ | $ | 4,522 | ​ | $ | 7,057 | ​ | ​
​

X
- Definition The entire disclosure pertaining to revenue. + References No definition available. + Details
Name: | plx_RevenueDisclosureTextBlock
Namespace Prefix: | plx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration